Search

Your search keyword '"Rongioletti, F"' showing total 1,236 results
Start Over Author "Rongioletti, F"
1,236 results on '"Rongioletti, F"'

216. Analysis of the results of an Italian multicenter study of the efficacy and tolerability of fluconazole 100 mg/day in the treatment of cutaneous mycoses

Author

Amerio, P. L., Cecchini, F., Bonci, A., Licastro Cicero, R., Cainelli, T., Rozzoni, M., Imberti, G., Cervetti, Ornella, Forte, M., De Marchi, R., Bossi, G., Offidani, A., Cellini, A., Simonetti, O., Rebora, A., Guarrera, M., Rongioletti, F., Santoianni, P., Scalvenzi, M., Califano, A., and Virgili, A.

Subjects
skin mycoses, drug therapy
Published
1999

226. [Cutaneous mucinosis]

Author

Rongioletti F and alfredo rebora

Subjects
Adult, Male, Scleroderma, Localized, Adolescent, Mucinoses, Myxedema, Humans, Lupus Erythematosus, Systemic, Female, Leg Dermatoses, Child, Eosinophilia-Myalgia Syndrome
Abstract

The cutaneous mucinoses are a heterogeneous group of diseases in which mucin accumulates in the skin or within the hair follicle. We divide the cutaneous mucinoses into two groups: the distinctive cutaneous mucinoses in which the mucin deposit is a distinctive histopathologic feature that manifests as a clinically specific lesion, and the diseases associated with histopathologic mucin deposition as an additional finding. This article deals with the clinical and histopathologic features and the treatment of the distinctive cutaneous mucinoses and updates their classification. They may be divided, according to the microscopic location of mucin, into dermal and follicular mucinoses. The former group includes; lichen myxedematosus, acral persistent papular mucinosis, reticular erythematous mucinosis, scleredema, dysthyroidotic mucinoses (i.e. localized myxedema, generalized myxedema, papular mucinoses associated with thyroid diseases), papular and nodular mucinosis associated with lupus erythematosus, self-healing juvenile cutaneous mucinosis, cutaneous mucinosis of the infancy, cutaneous toxic mucinoses (papular mucinosis of the toxic oil syndrome and of eosinophiliamyalgia syndrome), neuropathia mucinosa cutanea, cutaneous focal mucinosis, mucous cyst (digital and of the oral mucosa), while the latter group includes Pinkus' follicular mucinosis and urticaria-like follicular mucinosis.

Published
1993

232. Melanocytic nevi of the breast: a histologic case-control study

Author

Rongioletti, F., primary, Urso, C., additional, Batolo, D., additional, Chimenti, S., additional, Fanti, P. A., additional, Filotico, R., additional, Gianotti, R., additional, Innocenzi, D., additional, Lentini, M., additional, Tomasini, C., additional, Pippione, M., additional, and Rebora, A., additional

Published
2003
Full Text
View/download PDF

241. Glomeruloid hemangioma

Author

Rongioletti, F., primary, Gambini, C., additional, Lerza, R., additional, Fletcher CDM, Chan JKC, additional, GA, Hicklin, additional, and Rosai, J., additional

Published
1995
Full Text
View/download PDF

247. Schnitzler's syndrome: diagnosis, treatment, and follow-up.

Author

Simon, A., Asli, B., Braun‐Falco, M., Koning, H., Fermand, J.‐P., Grattan, C., Krause, K., Lachmann, H., Lenormand, C., Martinez‐Taboada, V., Maurer, M., Peters, M., Rizzi, R., Rongioletti, F., Ruzicka, T., Schnitzler, L., Schubert, B., Sibilia, J., and Lipsker, D.

Subjects
SCHNITZLER syndrome, AUTOIMMUNE disease diagnosis, FOLLOW-up studies (Medicine), INFLAMMATION, LITERATURE reviews, MONOCLONAL antibodies, THERAPEUTICS
Abstract

Schnitzler's syndrome is characterized by recurrent urticarial rash and monoclonal gammopathy, associated with clinical and biological signs of inflammation and a long-term risk of AA amyloidosis and overt lymphoproliferation. An extensive literature review was performed, and the following questions were addressed during an expert meeting: In whom should Schnitzler's syndrome be suspected? How should the diagnosis of Schnitzler's syndrome be established? How should a patient with Schnitzler's syndrome be treated? How should a patient with Schnitzler's syndrome be followed up?. A diagnosis of Schnitzler's syndrome is considered definite in any patient with two obligate criteria: a recurrent urticarial rash and a monoclonal IgM gammopathy, and two of the following minor criteria: recurrent fever, objective signs of abnormal bone remodeling, elevated CRP level or leukocytosis, and a neutrophilic infiltrate on skin biopsy. It is considered probable, if only 1 minor criterion is present. In patients with monoclonal IgG gammopathies, diagnosis is definite if three minor criteria are present and possible if two are present. First-line treatment in patients with significant alteration of quality of life or persistent elevation of markers of inflammation should be anakinra. Follow-up should include clinical evaluation, CBC and CRP every 3 months and MGUS as usually recommended. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results